UPnRIDE Robotics Overview
UPnRIDE Robotics aims to change the life of millions of wheelchair users by introducing the UPnRIDE - a smart robotic mobility device. UPnRIDE is far more than a wheelchair: It is the first and only wheeled motorized device, which enables wheelchair users to become mobile, while in a standing position, in practically any urban environment, both outdoors and indoors, and thus improves health, enhances self-esteem, and reduces medical and other disability costs. In February 2020, the US FDA cleared the company's Robotic Standing Wheelchair for marketing and use, making it available to wheelchair users and the elderly in the United States.
Cumulative Funding Raised Over Time ($)
$546KApr 2021
$2.6MFeb 2015
$4.3MJan 2017
$4.7MJun 2021
$5.4MNov 2020
$7.1MSep 2019
Latest News
growth-positive
Roaming Free, With The Super-Stable, Stand-Up "Wheelchair"
Dr Amit Goffer, the inventor of the bionic ReWalk, has developed a new mobility device called UpnRide. The device allows users to sit, stand and travel in an upright position, providing a solution for people with limited mobility. The device uses a patented auto-balancing gyroscope mechanism, allowing users to navigate urban environments safely. UpnRide is set to be marketed worldwide, with plans to sell hundreds of units next year and thousands in 2024. The device costs $32,000 and future models will incorporate obstacle detection and improved wheels.
CustomersExpand
growth-positive
FDA clears UPnRIDE Robotics' sit-to-stand wheelchair - Medical Design and Outsourcing
UPnRIDE Robotics has received FDA clearance for its robotic standing wheelchair, marking a significant milestone for the company. The wheelchair, which provides full functionality in both standing and sitting positions, is suitable for a wide range of wheelchair users. UPnRIDE Robotics plans to develop a distribution and service center network in the U.S. to expand its reach. The approval of the UPnRIDE standing wheelchair is seen as a positive growth opportunity for the company, as it aims to improve the quality of life for millions of people with walking impairments. The device offers numerous health, economic, and societal benefits, and reduces the visibility of disabilities for wheelchair users.
CustomersExpand
https://finance.yahoo.com/news/u-food-drug-administration-clears-130000744.html
U.S. Food and Drug Administration Clears the UPnRIDE™ Standing Wheelchair for Distribution in America BioSpace
growth-positive
CTalk: This Wheelchair Alternates Between Sitting and Standing Upright
Amit Goffer, president of standing wheelchair startup UPnRide, spoke at the OurCrowd Summit in Jerusalem about the need for the companys device. UPnRide develops a hoverboard-like device that allows paralyzed users to travel independently in an upright position. The company received FDA clearance for its wheeled robotic device in September.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $7.62M |
| Last funding | $384K |
| Stage | A |
| Rounds | 7 |
| Investors | 3 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | upnride.com |
Locations
HaCarmel Street 3, Yokne'am Illit, Israel
Photos & Videos
6 item(s)
UPnRIDE Robotics Business
Business models
B2B
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesAssistive DevicesTarget Customer
Healthcare & Life SciencesHealthcarePatientsConsumersDemographics & FamilySeniorsDisabilitiesCore Technology
Machinery & RoboticsTags (9)
home-caremedical-technologiesassistive-devicesdisabilitiesmedical-devicesroboticswellnessaccessibilityseniorsSolutions
{"title":"Healthcare / Medical Devices / Rehabilitation","description":"UPnRIDE Robotics manufactures an innovative standing wheelchair/mobility device that allows individuals with mobility impairments to stand and move independently, significantly improving their physical health, social interaction, and overall quality of life.","items":[{"name":"Revenue Growth","value":3,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Operational Efficiency","value":2,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Marginal / Localized","content":"Small, isolated improvement; measurable but not substantial."}},{"name":"Customer Acquisition","value":5,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Risk Mitigation","value":4,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":4,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}}]}
{"title":"Healthcare","description":"The UPnRIDE 2.0 is a robotic mobility device designed for individuals with lower limb disabilities, enabling them to transition between sitting and standing positions and navigate various environments, promoting independence and improving quality of life.","items":[{"name":"Revenue Growth","value":5,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Operational Efficiency","value":3,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Customer Acquisition","value":5,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Risk Mitigation","value":4,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":5,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}}]}
Use Cases
SRAlab patients' use feedbackRyan's use feedbackGeographic Markets
Western EuropeUnited StatesGlobalSoutheast AsiaUPnRIDE Robotics Financials
$7.62M
Total funding
Undisclosed
Capital raised
$384K
Last funding
A
Funding stage
7
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
$546KApr 2021
$2.6MFeb 2015
$4.3MJan 2017
$4.7MJun 2021
$5.4MNov 2020
$7.1MSep 2019
Private Equity Funding
A Round
Jun 2021
$384K
Undisclosed Investor(s)
Convertible Debt
Apr 2021
$546K
OurCrowd (Lead)
,
Undisclosed Investor(s)
A Round
Nov 2020
$690K
OurCrowd (Lead)
,
Together We Invest
A Round
Sep 2019
$1.69M
OurCrowd (Lead)
,
Together We Invest, Undisclosed Investor(s)
Convertible Debt
Jan 2017
$1.71M
OurCrowd, Undisclosed Investor(s)
Seed
Feb 2015
$2.08M
OurCrowd
Non-Equity Funding
GrantEvent
Jun 2014
$520K
Office of the Chief Scientist
UPnRIDE Robotics Lifecycle
Cumulative Funding Raised Over Time
$546KApr 2021
$2.6MFeb 2015
$4.3MJan 2017
$4.7MJun 2021
$5.4MNov 2020
$7.1MSep 2019
All Events
A Round
Jun 2021
$384K
Undisclosed Investor(s)
Convertible Debt
Apr 2021
$546K
OurCrowd (Lead)
,
Undisclosed Investor(s)
A Round
Nov 2020
$690K
OurCrowd (Lead)
,
Together We Invest
A Round
Sep 2019
$1.69M
OurCrowd (Lead)
,
Together We Invest, Undisclosed Investor(s)
Convertible Debt
Jan 2017
$1.71M
OurCrowd, Undisclosed Investor(s)
Seed
Feb 2015
$2.08M
OurCrowd
GrantEvent
Jun 2014
$520K
Office of the Chief Scientist
UPnRIDE Robotics News
18 articles
growth-positive
Roaming Free, With The Super-Stable, Stand-Up "Wheelchair"
Dr Amit Goffer, the inventor of the bionic ReWalk, has developed a new mobility device called UpnRide. The device allows users to sit, stand and travel in an upright position, providing a solution for people with limited mobility. The device uses a patented auto-balancing gyroscope mechanism, allowing users to navigate urban environments safely. UpnRide is set to be marketed worldwide, with plans to sell hundreds of units next year and thousands in 2024. The device costs $32,000 and future models will incorporate obstacle detection and improved wheels.
CustomersExpand
growth-positive
FDA clears UPnRIDE Robotics' sit-to-stand wheelchair - Medical Design and Outsourcing
UPnRIDE Robotics has received FDA clearance for its robotic standing wheelchair, marking a significant milestone for the company. The wheelchair, which provides full functionality in both standing and sitting positions, is suitable for a wide range of wheelchair users. UPnRIDE Robotics plans to develop a distribution and service center network in the U.S. to expand its reach. The approval of the UPnRIDE standing wheelchair is seen as a positive growth opportunity for the company, as it aims to improve the quality of life for millions of people with walking impairments. The device offers numerous health, economic, and societal benefits, and reduces the visibility of disabilities for wheelchair users.
CustomersExpand
https://finance.yahoo.com/news/u-food-drug-administration-clears-130000744.html
U.S. Food and Drug Administration Clears the UPnRIDE™ Standing Wheelchair for Distribution in America BioSpace
growth-positive
CTalk: This Wheelchair Alternates Between Sitting and Standing Upright
Amit Goffer, president of standing wheelchair startup UPnRide, spoke at the OurCrowd Summit in Jerusalem about the need for the companys device. UPnRide develops a hoverboard-like device that allows paralyzed users to travel independently in an upright position. The company received FDA clearance for its wheeled robotic device in September.
Customers
growth-positive
Accessibility Startup UPnRIDE Receives FDA Clearance
Israeli accessibility startup UPnRIDE Robotics Ltd. has received U.S. Food and Drug Administration (FDA) clearance for its wheeled robotic device. The device, which is similar to a hoverboard, allows users who are paralyzed or otherwise unable to stand on their own to travel independently in an upright position on various terrains. Earlier this month, UPnRIDE announced that it had received $1 million in funding through Israeli equity-based crowdfunding platform Together.
Investment
growth-positive
Advanced wheelchair co UPnRIDE raises NIS 2.2m
UPnRIDE, a company that has developed a special wheelchair for people with paralysis, has raised NIS 2.2 million through Together Pharmas crowdfunding platform. The investors are from Togethers club of eligible investors. UPnRIDE is now raising more money from the general public. The company has already signed distribution agreements in the UK and Hong Kong, and its wheelchairs are being tested by the US army. 2,000 people are interested in UPnRIDEs product.
InvestmentCustomers
growth-positive
Israeli device lets wheelchair-bound groom stand under chuppah
UPnRIDE Robotics, the company behind the UPnRIDE 1.1 mobility device, is experiencing growth-positive impact as it transitions from research-and-development to market. The device, invented by Amit Goffer, allows wheelchair-bound individuals to recline, stand, and navigate indoors and outdoors. The company is currently raising funds, seeking FDA clearance, and conducting usability studies. Additionally, a major study is being conducted to determine the health benefits for UPnRIDE users. UPnRIDE plans to use proceeds from the current funding round for marketing, mass production, and developing advanced and new models. The smart wheelchairs will be manufactured by Sanmina, an American electronics manufacturing services provider.
InvestmentExpand
growth-positive
10 Innovations From Israel That Prove We're On Our Way To Living In The Future
The article discusses Watergen, an Israeli technology company that creates drinking water from air. The companys technology uses humidity from the air to produce clean drinking water. Watergen machines were recently used to assist Puerto Rico after Hurricane Maria. The article highlights the innovation and potential impact of Watergens technology in addressing the global challenge of finding fresh drinking water. The impact on the company is growth-positive as it showcases the companys capabilities and potential for providing clean water solutions.
Customers
growth-positive
Essential Interview: Exoskeleton Inventor, UPnRIDE Founder Amit Goffer
The article discusses UPnRIDE Robotics Ltd., a startup working on a wheeled robotic device for users who are physically unable to stand or walk. The company was founded by Dr. Amit Goffer, who previously created the ReWalk system. UPnRIDE aims to provide full mobility in a standing position in almost any urban environment. The article includes an interview with Dr. Goffer, where he discusses the development of the ReWalk exoskeleton and the lessons he learned from it. He also talks about the business model for UPnRIDE and the technical challenges the company faces. The article mentions that UPnRIDE is currently undergoing clinical trials and will be sold in Europe and the US. The price of an UPnRIDE device is $25,000 to $30,000.
Customers
How a paralyzed man reinvented the wheelchair to help people walk again
Unknown
Access Restricted
The article is inaccessible and does not provide any information about a specific company or event.
growth-negative
UPnRIDE lets wheelchair users stand and ride
ReWalk Robotics, a medical technology company, has faced challenges in meeting market expectations and obtaining insurance reimbursement for its exoskeleton product that helps people with spinal cord injuries walk again. The company lost half of its IPO value and currently has a market cap of $36 million. Despite these challenges, the product has the potential to significantly improve the health of users. ReWalks founder, Dr. Amit Goffer, who is paralyzed himself, has left the company and founded UpnRIDE Robotics, a startup developing a new generation of devices for people with paralysis. The new product aims to address the limitations of ReWalks product and serve a larger market. The article was published on March 7, 2017.
Customers
N/A
This-wheelchair-would-allow-quadriplegics-to-stand cnn
The article discusses a wheelchair that allows quadriplegics to stand and sit at will. It highlights the potential impact of this innovation on the lives of quadriplegics. The article does not mention any specific company or provide any information about the impact on a company. The key theme of the article is the development of a wheelchair for quadriplegics. There are no structured issues discussed in the article. The article does not mention any investors, acquisition or investment amounts, layoffs, customers, or partners. The date of the event described in the article is not provided. The confidence level of the answer is 8.
growth-positive
New wheelchair lets you cruise through town standing
Israeli start-up UPnRIDE Robotics is launching a self-stabilizing wheelchair at a medical conference in Germany. The company hopes to bring the device to market next year, pending regulatory approval and assistance from health insurance companies. The wheelchair, created by Amit Goffer, uses a gyroscope and self-stabilizing software to allow users to maneuver upright over uneven terrain. Clinical trials will be conducted by the U.S. veteran association in New York and the U.S. Department of Veterans Affairs. The wheelchair aims to provide mobility and improve the quality of life for individuals with spinal cord injuries. The target price for the wheelchair is expected to be in the middle range of high-end wheelchairs, which cost between $15,000 and $50,000.
Customers
growth-positive
New wheelchair lets you cruise through town standing
Israeli start-up UPnRIDE Robotics is launching a self-stabilising wheelchair at a medical conference in Germany. The company hopes to bring the device to market next year, pending regulatory approval and assistance from health insurance companies. UPnRIDE was founded by Amit Goffer, who previously created a robotic exoskeleton. The new wheelchair uses a gyroscope and self-stabilising software to allow users to manoeuvre upright over uneven terrain. Clinical trials will be conducted by the US Department of Veterans Affairs and a neurological rehabilitation department in Israel. The wheelchair aims to provide mobility and health benefits for people with spinal cord injuries.
Customers
growth-positive
ReWalk inventor rolls out revolutionary standing wheelchair
UPnRIDE Robotics, an Israeli company, is set to unveil its first commercial model, UPnRIDE 1.0, at a trade fair in September. The UPnRIDE mobility device is designed to provide enhanced mobility for wheelchair and scooter users, including paraplegics and quadriplegics. The device allows users to transition between sitting and standing positions and utilizes cutting-edge motion technology for automatic balancing and stability. The company is currently raising Series B funds and plans to have the first users ride the UPnRIDE by early 2017. The introduction of UPnRIDE is seen as a revolution in the wheelchair industry, providing users with a fresh perspective and numerous health benefits.
Investment
growth-positive
12 Israeli Technologies Changing the Lives of the Disabled in 2015
The article discusses 12 technological breakthroughs coming out of Israel that are aimed at improving the lives of the disabled. One of the companies mentioned is ReWalk, which has developed a bionic exoskeleton that enables people with spinal cord injuries to regain mobility. ReWalk went public on the Nasdaq in 2014 and has FDA approval and CE marks. The article highlights the impact of Israeli tech on peoples lives and emphasizes the countrys dedication to enabling the disabled. The date of the event described in the article is not provided.
Customers
UPnRIDE Robotics Team
Dr. Amit Goffer
CTO, Co-Founder
Founder
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
UPnRIDE Robotics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514976307 |
| Crunchbase | upnride |
| Phone | +97246110061 |
| Creator | Fredrik Liljedahl |
| Creator email | fredrik.liljedahl@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2022-12-21T00:00:00.000Z |
| Created | 2016-08-22T00:00:00.000Z |
| Claimed | Yes |